Galsulfase

ATC A16AB08 · 7 markets · 8 records

Galsulfase 7 markets · 8 records Forms

AU 2 records · 2 strengths

  • 5 mginjectionNAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial unknown

Records without a stated strength · 1 NAGLAZYME

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 5 mg/5 mLinjectionNaglazyme 5mg/5ml solution for infusion vials also in SG

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 5 mg/5 mLinjectionNAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML also in GB

HK 1 records · 1 strengths

    Records without a stated strength · 1 NAGLAZYME CONC SOLN FOR IV INFUSION 1MG/ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 NAGLAZYME

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.